Bacterial fatty acid biosynthesis is a central metabolic process, intricately linked to membrane formation and pathogenicity. The type II fatty acid synthesis (FASII) pathway, distinct from the ...

Metabolic engineering of Escherichia coli for fatty acid biosynthesis has emerged as a promising strategy to produce renewable biofuels and value‐added chemicals. Recent advances have focused on ...

ABLE-32: A randomized, controlled, phase 3b clinical trial of nadofaragene firadenovec-vncg versus observation in patients with intermediate-risk non–muscle-invasive bladder cancer. This is an ASCO ...

This study is led by Prof. Dr. Shengying Li (State Key Laboratory of Microbial Technology, Shandong University) and Ass. Prof. Dr. Biaobiao Zhang (School of Science, Westlake University). The team ...

Metabolic Dysfunction-Associated Steatotic Liver Disease（MASLD） is characterized by excessive accumulation of lipids in hepatocytes and is closely associated with the rapid rise in insulin resistance, ...

While C13 fatty acid remains elusive in human plasma, new findings reveal its microbial origins, unique metabolic pathways, and potential as a biomarker for understanding how diet and the gut ...